Viewing nowD-MAC Tablet 7000 IU (Concentrated Cholecalciferol Granule)
Cholecalciferol Concentrate Granules 70mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

MFDS item code 201702372 · Approved 2017.05.15
Treatment and prevention of vitamin D deficiency, adjunct therapy for osteoporosis
This medication helps to treat vitamin D deficiency and prevent it in patients at risk of vitamin D deficiency. It also acts as an adjunct therapy for osteoporosis in patients with vitamin D deficiency or in at-risk populations, improving bone health. It is used effectively to manage problems related to vitamin D deficiency.
Adults: Take 1 tablet (equivalent to 7,000 IU of cholecalciferol) once a week.
This medication should not be used in patients with hypersensitivity to the components. It should not be administered to patients who have excessive vitamin D or those with kidney stones or nephrocalcinosis. Patients with hypercalcemia or hypercalciuria may also be at risk when using this medication. It should not be given to patients with conditions such as myeloma, bone metastasis, or primary hyperparathyroidism, or to patients with severe renal dysfunction. Additionally, patients with genetic lactose intolerance should not use this medication. Patients with renal dysfunction or granulomatous diseases such as sarcoidosis should use this medication cautiously, and calcium levels should be frequently checked through blood and urine tests under a physician's guidance. When taking this medication, side effects such as hypercalcemia, rash, and urticaria may occur, and any unusual symptoms should be reported to a healthcare provider immediately. Especially, patients with poor kidney function should regularly check calcium and phosphate levels, and monitor for soft tissue calcification risk. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, considering potential effects on newborns. This medication is not recommended for children under 12 years of age. Additionally, there may be interactions with other vitamin D preparations or certain medications, so it is essential to inform the doctor or pharmacist before taking it. In case of overdose, symptoms of hypercalcemia such as vomiting, lethargy, thirst, and dizziness may occur, and the medication should be stopped immediately, and a healthcare institution should be visited. This medication should be stored in its original container to protect it from light, and it is crucial to follow the correct dosage and precautions.
Urticaria, facial swelling or swelling of the larynx, hypercalcemia, arrhythmia, coma, death, renal calcification, kidney stones
Itching, rash
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that effectively shields it from light. Additionally, it is important to maintain room temperature, specifically between 1 degree and 30 degrees Celsius, when storing the medication. This helps to preserve the effectiveness and safety of the medication.
Bright yellowish-white convex round film-coated tablet
12 tablets (4 tablets PTP*3)/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCholecalciferol Concentrate Granules 70mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.

Cholecalciferol Concentrate Granules 10mg
Tablet · OTC medication
Darim Biotech Co., Ltd.

Cholecalciferol Concentrate Granules 300mg
Tablet · Prescription medication
Darim Biotech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.